Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248025.RAyD_qVf1DeRJ1xhfnDWa2Tueg1xDAkTlQeIAX3ejNLKk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248025.RAyD_qVf1DeRJ1xhfnDWa2Tueg1xDAkTlQeIAX3ejNLKk130_assertion type Assertion NP1248025.RAyD_qVf1DeRJ1xhfnDWa2Tueg1xDAkTlQeIAX3ejNLKk130_head.
- NP1248025.RAyD_qVf1DeRJ1xhfnDWa2Tueg1xDAkTlQeIAX3ejNLKk130_assertion description "[We demonstrated that NAM reduces PARP activity in vitro, and in cells subjected or not to DNA damage, it also reduces the viability of breast cancer cell lines and synergyzes the cytotoxicity of cisplatin in MDA-MB-436 and MCF-7 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248025.RAyD_qVf1DeRJ1xhfnDWa2Tueg1xDAkTlQeIAX3ejNLKk130_provenance.
- NP1248025.RAyD_qVf1DeRJ1xhfnDWa2Tueg1xDAkTlQeIAX3ejNLKk130_assertion evidence source_evidence_literature NP1248025.RAyD_qVf1DeRJ1xhfnDWa2Tueg1xDAkTlQeIAX3ejNLKk130_provenance.
- NP1248025.RAyD_qVf1DeRJ1xhfnDWa2Tueg1xDAkTlQeIAX3ejNLKk130_assertion SIO_000772 25504347 NP1248025.RAyD_qVf1DeRJ1xhfnDWa2Tueg1xDAkTlQeIAX3ejNLKk130_provenance.
- NP1248025.RAyD_qVf1DeRJ1xhfnDWa2Tueg1xDAkTlQeIAX3ejNLKk130_assertion wasDerivedFrom befree-2016 NP1248025.RAyD_qVf1DeRJ1xhfnDWa2Tueg1xDAkTlQeIAX3ejNLKk130_provenance.
- NP1248025.RAyD_qVf1DeRJ1xhfnDWa2Tueg1xDAkTlQeIAX3ejNLKk130_assertion wasGeneratedBy ECO_0000203 NP1248025.RAyD_qVf1DeRJ1xhfnDWa2Tueg1xDAkTlQeIAX3ejNLKk130_provenance.